Efficacy and safety of pumecitinib 3% gel in treating mild-to-moderate atopic dermatitis: a multicentre randomized double-blind parallel placebo-controlled phase IIb clinical trial

Zhang Li, Mingyue Wang, Litao Zhang et al.|British Journal of Dermatology|2025

Cited by 0